Rare
lephants
Screener
Toggle theme
Anbio Biotechnology
NNNN
·
Healthcare, Drug Manufacturers - General, Germany
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2024
FY2023
FY2022
Total Cash from Operations:
$2.7M
Line Item
Value
% of Total
Other Financing
$344.6K
12.7%
Working Capital
$292.5K
10.8%
Net Cash Flow
$2.1M
76.5%
Download CSV
